DE602006007832D1 - Benzotriazolderivate als cannabinoidrezeptorantagonisten - Google Patents

Benzotriazolderivate als cannabinoidrezeptorantagonisten

Info

Publication number
DE602006007832D1
DE602006007832D1 DE602006007832T DE602006007832T DE602006007832D1 DE 602006007832 D1 DE602006007832 D1 DE 602006007832D1 DE 602006007832 T DE602006007832 T DE 602006007832T DE 602006007832 T DE602006007832 T DE 602006007832T DE 602006007832 D1 DE602006007832 D1 DE 602006007832D1
Authority
DE
Germany
Prior art keywords
cannabinoidrezeptorantagonisten
benzotriazol derivatives
benzotriazol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006007832T
Other languages
English (en)
Inventor
Monique Jenny Marie Berwaer
Joannes Theodorus Maria Linders
Peter John King
Hecke Geert Maria Robert Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE602006007832D1 publication Critical patent/DE602006007832D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006007832T 2005-04-29 2006-04-24 Benzotriazolderivate als cannabinoidrezeptorantagonisten Active DE602006007832D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103597 2005-04-29
PCT/EP2006/061787 WO2006117307A2 (en) 2005-04-29 2006-04-24 Benzotriazole derivatives as cannabinoid receptor antagonists

Publications (1)

Publication Number Publication Date
DE602006007832D1 true DE602006007832D1 (de) 2009-08-27

Family

ID=35841851

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006007832T Active DE602006007832D1 (de) 2005-04-29 2006-04-24 Benzotriazolderivate als cannabinoidrezeptorantagonisten

Country Status (13)

Country Link
US (1) US20080194656A1 (de)
EP (1) EP1874304B1 (de)
JP (1) JP5137816B2 (de)
KR (1) KR20080000584A (de)
CN (1) CN101166529B (de)
AU (1) AU2006243246A1 (de)
BR (1) BRPI0609866A2 (de)
CA (1) CA2600052A1 (de)
DE (1) DE602006007832D1 (de)
EA (1) EA200702377A1 (de)
ES (1) ES2329614T3 (de)
MX (1) MX2007013454A (de)
WO (1) WO2006117307A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
FI3392252T3 (fi) 2011-08-23 2024-01-08 Libertas Bio Inc Pyrimidopyridazinoniyhdisteet ja niiden käyttö
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
WO2014170902A1 (en) 2013-04-17 2014-10-23 Ariel - University Research And Development Company, Ltd. Cb2 receptor ligands for the treatment of psychiatric disorders
CN117503775A (zh) 2017-04-28 2024-02-06 自由生物有限公司 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型
WO2022128050A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammation and pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
US4943574A (en) * 1987-06-01 1990-07-24 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
US7319110B2 (en) * 2002-09-19 2008-01-15 Solvay Pharmaceuticals B.V. 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
JP4786147B2 (ja) * 2003-06-26 2011-10-05 武田薬品工業株式会社 カンナビノイド受容体調節剤

Also Published As

Publication number Publication date
EP1874304B1 (de) 2009-07-15
US20080194656A1 (en) 2008-08-14
EA200702377A1 (ru) 2008-02-28
WO2006117307A2 (en) 2006-11-09
WO2006117307B1 (en) 2007-04-26
JP2008539197A (ja) 2008-11-13
BRPI0609866A2 (pt) 2010-05-11
CN101166529B (zh) 2011-11-16
KR20080000584A (ko) 2008-01-02
WO2006117307A3 (en) 2007-03-08
JP5137816B2 (ja) 2013-02-06
CN101166529A (zh) 2008-04-23
MX2007013454A (es) 2008-01-21
ES2329614T3 (es) 2009-11-27
CA2600052A1 (en) 2006-11-09
EP1874304A2 (de) 2008-01-09
AU2006243246A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
ATE460417T1 (de) Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
DK1928882T3 (da) (s)-n-methylnaltrexon
ATE517886T1 (de) Pyrazolderivate
ATE479676T1 (de) Als antikoagulanzien verwendbare phenylglycinamid-derivate
ATE408603T1 (de) Pyrazolylcarboxanilide
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
CR9974A (es) Gavión
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE549324T1 (de) Tetrahydrobenzoxazine
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
CR10039A (es) Derivados espirocíclicos
DE602006015186D1 (de) Oxindole als kinaseinhibitoren
DE602006014973D1 (de) Neuartige cercosporamidderivate
DE602006007832D1 (de) Benzotriazolderivate als cannabinoidrezeptorantagonisten
ATE485368T1 (de) Hiv - impfung
DE102005052834B8 (de) Punktschweißklebverbindung
ATE541837T1 (de) Oxaphenanthren-derivate
AT501523A3 (de) Estrich
AT501968A3 (de) Mitführhilfe
DE112006001399A5 (de) Baueinheit
DE602006019209D1 (de) Fluoroalkylpyrrolidin-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition